Search For "mild"
Hetero announces interim clinical results from Phase III clinical trials o
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 9 (ANI): Hetero, a globally renowned vertically integrated pharmaceutical organization, on Friday announced the interim clinical results from Phase III clinical trials of Molnupiravir in mild Covid-19 patients conducted across multiple COVID-19 dedicated h
Read More
Mild quake hits Haryana's Jhajjar, tremors felt in Delhi
Updated : 4 years, 8 months ago IST
New Delhi [India], July 5 (ANI): An earthquake of magnitude 3.7 hit Haryana's Jhajjar late on Monday night and mild tremors were also felt in New Delhi and surrounding areas of the National Capital Region.
Read More
Significant surge in antibiotic sales in India during COVID-19 first wave,
Updated : 4 years, 8 months ago IST
New Delhi [India], July 2 (ANI): Antibiotic sales soared during the first COVID-19 wave in India last year, according to a study that suggests that drugs, especially azithromycin, were used to treat mild and moderate cases.
Read More
India likely to have COVID vaccine for children above 2 years by September
Updated : 4 years, 8 months ago IST
New Delhi [India], June 23 (ANI): Noting that children usually have a mild disease but there is a need to develop COVID-19 vaccines for them, AIIMS Delhi Director Dr Randeep Guleria has said Bharat Biotech and other companies are doing trials at a very fast pace and hoped that data will l
Read More
Ayurvedic medical camp starts in Vijayawada for COVID patients
Updated : 4 years, 8 months ago IST
Vijayawada (Andhra Pradesh) [India], June 22 (ANI): A free Ayurvedic medical camp started at Government Ayurvedic Medical College Vijayawada for people with asymptomatic, mild or moderate COVID-19 symptoms.
Read More
Boeing-SELCO-KSPCL-DFY set up 100-Bed COVID-care centre in Yelahanka, Beng
Updated : 4 years, 9 months ago IST
Bengaluru (Karnataka) [India], June 19 (ANI/News Voir): Boeing India, with Doctors for You (DFY) and SELCO Foundation, today announced that they have established a 100 oxygenated bed facility at Karnataka State Power Corporation Ltd. (KSPCL), Yelahanka, to treat mild-to-moderate COVID-19
Read More
92 pc of fully vaccinated healthcare workers developed only mild illness o
Updated : 4 years, 9 months ago IST
New Delhi [India], June 17 (ANI): A study released by Fortis Healthcare on Thursday found that 92 per cent of fully vaccinated healthcare workers developed only mild illness on acquiring COVID-19 infection after vaccination.
Read More
Centre issues guidelines for COVID management in children, discourages use
Updated : 4 years, 9 months ago IST
New Delhi [India], June 10 (ANI): The Director General of Health Services (DGHC) under the Union Health Ministry on Wednesday issued guidelines for the management of COVID-19 in children below 18 years of age, according to which use of Remdesivir, an emergency use authorisation drug, has
Read More
Biden reaches UK for G7 summit, says America, other democracies standing t
Updated : 4 years, 9 months ago IST
London [UK], June 10 (ANI): US President Joe Biden arrived in the United Kingdom to attend the Group of Seven Summit in Cornwall, commencing his first overseas trip as president.
Read More
COVID-19: NITI Aayog, Piramal Foundation launch 'Surakshit Hum Surakshit T
Updated : 4 years, 9 months ago IST
New Delhi [India], June 8 (ANI): NITI Aayog and Piramal Foundation on Tuesday launched 'Surakshit Hum Surakshit Tum Abhiyaan' in 112 aspirational districts to assist district administrations in providing home-care support to COVID-19 patients who are asymptomatic or have mild symptoms. Read More
27 black fungus patients suffer adverse reactions after Amphotericin-B sho
Updated : 4 years, 9 months ago IST
Sagar (Madhya Pradesh) [India], June 7 (ANI): As many as 27 black fungus patients complained about mild adverse reactions after were given shots of Amphotericin-B at the government Bundelkhand Medical College (BMC) in Madhya Pradesh's Sagar district, officials said on Saturday.
Read More
Monoclonal Antibody treatment begins at Delhi's LNJP hospital
Updated : 4 years, 9 months ago IST
New Delhi [India], June 6 (ANI): The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" patients who are Covid positive is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) free of cost.
Read More